Non-active code 2014 HCPCS Q0178
Hydroxyzine pamoate, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

  • Added on Wednesday, April 01, 1998
  • Terminated on Tuesday, December 31, 2013: do not use.
  • Status changed on Wednesday, January 01, 2014 to: Discontinue procedure or modifier code
  • BETOS Classification: Chemotherapy
  • Medicare coverage status: Special coverage instructions apply

  Q0177    Q0179